Symbols / ELVN Stock $43.80 -1.44% Enliven Therapeutics, Inc.

Healthcare • Biotechnology • United States • NMS
ELVN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
About

No company description available for this symbol.

Stock Fundamentals
Scroll to Statements
Market Cap 2.62B Enterprise Value 2.20B Income -103.69M Sales — Book/sh 7.73 Cash/sh 7.74
Dividend Yield — Payout 0.00% Employees 60 IPO — P/E — Forward P/E -17.24
PEG — P/S — P/B 5.66 P/C — EV/EBITDA -18.39 EV/Sales —
Quick Ratio 27.92 Current Ratio 28.66 Debt/Eq 0.09 LT Debt/Eq — EPS (ttm) -1.83 EPS next Y -2.54
EPS Growth — Revenue Growth — Earnings 2026-05-13 ROA -18.65% ROE -26.95% ROIC —
Gross Margin 0.00% Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 59.80M Shs Float 34.14M Short Float 14.36%
Short Ratio 3.94 Short Interest — 52W High 48.53 52W Low 14.79 Beta 0.49 Avg Volume 1.15M
Volume 105.85K Target Price $51.29 Recom Strong_buy Prev Close $44.44 Price $43.80 Change -1.44%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-14.44
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest ELVN news

No recent news from Yahoo. Try the RSS feed for latest ELVN news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-17 COLLINS HELEN LOUISE Officer — 5,000 $45.81 $238,352
2026-04-17 COLLINS HELEN LOUISE Officer — 5,000 $2.48 $12,400
2026-03-25 COLLINS HELEN LOUISE Officer — 40,000 $35.10 $1,404,024
2026-03-25 COLLINS HELEN LOUISE Officer — 40,000 $2.48 $99,200
2026-03-17 COLLINS HELEN LOUISE Officer — 5,000 $27.76 $138,800
2026-03-17 COLLINS HELEN LOUISE Officer — 5,000 $2.48 $12,400
2026-03-10 COLLINS HELEN LOUISE Officer — 40,000 $30.02 $1,202,638
2026-03-10 COLLINS HELEN LOUISE Officer — 40,000 $2.48 $99,200
2026-03-06 HOHL BENJAMIN Chief Financial Officer — 10,000 $29.58 $295,839
2026-02-17 HEYMAN RICHARD A Director — 1,230 $26.18 $32,196
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category